Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes
- PMID: 29124114
- PMCID: PMC5671632
- DOI: 10.1016/j.trci.2017.02.003
Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes
Abstract
Introduction: Antipsychotics are used for managing behavioral and psychological symptoms of dementia (BPSD) but have risks. Anticholinergics can worsen outcomes in dementia. The Improving Antipsychotic Appropriateness in Dementia Patients educational program (IA-ADAPT) and Centers for Medicare and Medicaid Services Partnership to Improve Dementia Care (CMS Partnership) promote improved care for BPSD. The purpose of this study was to evaluate the impact of these programs on medication use and BPSD among nursing home residents.
Methods: This quasi-experimental longitudinal study used Medicare and assessment data for Iowa nursing home residents from April 2011 to December 2012. Residents were required to be eligible for six continuous months for inclusion. Antipsychotic use and anticholinergic use were evaluated on a monthly basis, and changes in BPSD were tracked using assessment data. Results are presented as odds ratios (ORs) per month after exposure to the IA-ADAPT or the start of the CMS Partnership.
Results: Of 426 eligible Iowa nursing homes, 114 were exposed to the IA-ADAPT in 2012. Nursing home exposure to the IA-ADAPT was associated with reduced antipsychotic use (OR [95% CI] = 0.92 [0.89-0.95]) and anticholinergic use (OR [95% CI] = 0.95 [0.92-0.98]), reduced use of excessive antipsychotic doses per CMS guidance (OR [95% CI] = 0.80 [0.75-0.86]), increased odds of a potentially appropriate indication among antipsychotic users (OR [95% CI] = 1.04 [1.00-1.09]), and decreased documentation of verbal aggression (OR [95% CI] = 0.96 [0.94-0.99]). Facilities with two or more IA-ADAPT exposures had greater reductions in antipsychotic and anticholinergic use than those with only one. The CMS Partnership was associated with reduced antipsychotic use (OR [95% CI] = 0.96 [0.94-0.98]) and decreased documentation of any measured BPSD (OR [95% CI] = 0.98 [0.97-0.99]) as well as delirium specifically (OR [95% CI] = 0.98 [0.96-0.99]).
Discussion: This study suggests that the IA-ADAPT and the CMS Partnership improved medication use with no adverse impact on BPSD.
Keywords: Anticholinergics; Antipsychotics; Dementia; Education; Nursing home.
Similar articles
-
Association of nursing home antipsychotic reduction policies with antipsychotic use in community dwellers with dementia.J Am Geriatr Soc. 2025 Jan;73(1):214-222. doi: 10.1111/jgs.19184. Epub 2024 Sep 6. J Am Geriatr Soc. 2025. PMID: 39242359 Free PMC article.
-
Trends in antipsychotic prescribing among long-term care residents receiving hospice care.J Am Geriatr Soc. 2021 Aug;69(8):2152-2162. doi: 10.1111/jgs.17172. Epub 2021 Apr 9. J Am Geriatr Soc. 2021. PMID: 33837537 Free PMC article.
-
DEprescribing and Care to reduce Antipsychotics in DEmentia (DECADE)-A Hybrid Effectiveness-Implementation Pilot Study.Am J Geriatr Psychiatry. 2025 Jul;33(7):730-745. doi: 10.1016/j.jagp.2025.03.012. Epub 2025 Apr 8. Am J Geriatr Psychiatry. 2025. PMID: 40268632
-
Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014.JAMA Intern Med. 2018 May 1;178(5):640-647. doi: 10.1001/jamainternmed.2018.0379. JAMA Intern Med. 2018. PMID: 29550856 Free PMC article.
-
Pharmacological treatment of behavioral and psychological symptoms of dementia (BPSD) in nursing homes: development of practice recommendations in a Swiss canton.J Am Med Dir Assoc. 2008 Jul;9(6):439-48. doi: 10.1016/j.jamda.2008.04.003. J Am Med Dir Assoc. 2008. PMID: 18585647 Review.
Cited by
-
Risk Indicators Improve the Prescription Quality of Drugs with Anticholinergic Properties in Nursing Homes.Int J Environ Res Public Health. 2021 Dec 31;19(1):423. doi: 10.3390/ijerph19010423. Int J Environ Res Public Health. 2021. PMID: 35010682 Free PMC article.
-
Effectiveness of Interventions to Improve the Anticholinergic Prescribing Practice in Older Adults: A Systematic Review.J Clin Med. 2022 Jan 28;11(3):714. doi: 10.3390/jcm11030714. J Clin Med. 2022. PMID: 35160166 Free PMC article. Review.
-
Developing a complex intervention targeting antipsychotic prescribing to nursing home residents with dementia.HRB Open Res. 2021 Feb 19;4:23. doi: 10.12688/hrbopenres.13228.1. eCollection 2021. HRB Open Res. 2021. PMID: 34136749 Free PMC article.
-
What's behind delirium: is there a specific role for medications?Eur Geriatr Med. 2025 Jul 10. doi: 10.1007/s41999-025-01269-x. Online ahead of print. Eur Geriatr Med. 2025. PMID: 40638064 Review.
-
Antipsychotic initiation and new diagnoses excluded from quality-measure reporting among Veterans in community nursing homes contracted by the Veterans Health Administration in the United States.Int J Methods Psychiatr Res. 2022 Mar;31(1):e1898. doi: 10.1002/mpr.1898. Epub 2021 Nov 5. Int J Methods Psychiatr Res. 2022. PMID: 34739736 Free PMC article.
References
-
- Department of Health. The Use of Antipsychotic Medication for People With Dementia: Time for Action. A Report for the Minister of State for Care Services by Professor Sube Banerjee. Available at: https://www.rcpsych.ac.uk/pdf/Antipsychotic%20Bannerjee%20Report.pdf. Accessed January 10, 2017.
-
- Maglione M., Ruelaz Maher A., Hu J., Wang Z., Shanman R., Shekelle P.G. Agency for Healthcare Research and Quality; Rockville, MD: 2011. Off-Label Use of Atypical Antipsychotics: An Update. Comparative Effectiveness Review No. 43.https://www.effectivehealthcare.ahrq.gov/ehc/products/150/778/CER43_Off-... Prepared by the Southern California Evidence-based Practice Center under Contract No. HHSA290-2007-10062-1. Available at: - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous